Indicators
Indicators
Value
Direction
MACD(12,26,9)
-0.053
Neutral
RSI(14)
62.549
Neutral
STOCH(KDJ)(9,3,3)
53.605
Buy
ATR(14)
0.290
High Vlolatility
CCI(14)
203.515
Overbought
Williams %R
20.686
Buy
TRIX(12,20)
-0.352
Sell
StochRSI(14)
100.000
Buy
Search
WGRX
WGRXAdd to Watchlist
3.520USD
0.0000.00%
Close 07-21 16:00（ET）Quotes delayed by 15 min
9.00MMarket Cap
LossP/E TTM
View Detailed Chart
TradingKey ChartIntraday
1m
30m
1h
D
W
M
D
Today
0.00%
5 Days
0.00%
1 Month
+13.55%
6 Months
+881.60%
Year to Date
+781.10%
1 Year
+305.58%
Key Figures
--Open
0.000High
0.00Volume
LossP/E TTM
--P/E Dynamic
--Dividend TTM
22.98%Turnover Ratio
3.520Prev. Close
0.000Low
0.00Turnover
LossP/E Static
-0.56P/B
0.00%Div Yield TTM
-173.68%ROA
128.00052wk High
27.39Volume Ratio
-6.86MNet Profit
2.39MShares
-0.8760EPS TTM
--Beta
-927.67%ROE
3.04052wk Low
39.48%Amplitude
-11.97%Gross Margin
9.00MMarket Cap
-1.06Reward/Risk
11.83%Risk Rate
TradingKey Stock Score of WGRX
Currency: USD Updated: 2026-07-21Key Insights
Wellgistics Health Inc's fundamentals are relatively weak, and its growth potential is good.Its valuation is considered fairly valued, ranking 147 out of 203 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.In the medium term, the stock price is expected to trend up.Despite a good stock market performance over the past month, the company shows weak fundamentals and technicals, which don't support the current trend.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
WGRX's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Media Coverage
Last 24 hours
Coverage Level
Very Low
Very High
Neutral
WGRX Highlights
StrengthsRisks
Wellgistics Health, Inc. is a holding company, which conducts business through two wholly owned subsidiaries, Wood Sage, LLC and Wellgistics LLC and two indirect subsidiaries, Alliance Pharma Solutions, LLC and Community Specialty Pharmacy, LLC. It focuses on specialty medications and a community-based model offering home delivery services to patients. It is focused on improving the lives of patients while delivering solutions for pharmacies, providers, pharmaceutical manufacturers, and payors. Its technology platform, DelivMeds, serves as a pharmacy hub and allows for clinical services to be connected to the Company’s health pharmacy operations. This platform will allow for an end-to-end mobile application solution whereby patients can digitize their prescription journey. The solution helps to preserve patient autonomy, improve prescription price transparency, and provide additional concierge services. Its products include Kyzatrex and Semaglutide and Tirzepatide.
Growing
The company is in a growing phase, with the latest annual income totaling USD 23.34M.
High Profit Growth
The company's net income leads the industry, with the latest annual income totaling USD 23.34M.
Undervalued
The company’s latest PE is -4.02, at a low 3-year percentile range.
Held by Steven Cohen
Star Investor Steven Cohen holds 15.25 shares of this stock.
Analyst Rating
Based on
0
analysts
--
Current Rating
--
Target Price
--
Upside Space
WGRX News
More news coming soon, stay tuned...
Indicators
Moving Average
Indicators
Value
Direction
MA5
2.876
Buy
MA10
2.912
Buy
MA20
2.958
Buy
MA50
2.636
Buy
MA100
1.388
Buy
MA200
0.942
Buy
Financial Indicators
EPS
Relevant data have not been disclosed by the company yet.
Total revenue
Relevant data have not been disclosed by the company yet.
WGRX Info
Wellgistics Health, Inc. is a holding company, which conducts business through two wholly owned subsidiaries, Wood Sage, LLC and Wellgistics LLC and two indirect subsidiaries, Alliance Pharma Solutions, LLC and Community Specialty Pharmacy, LLC. It focuses on specialty medications and a community-based model offering home delivery services to patients. It is focused on improving the lives of patients while delivering solutions for pharmacies, providers, pharmaceutical manufacturers, and payors. Its technology platform, DelivMeds, serves as a pharmacy hub and allows for clinical services to be connected to the Company’s health pharmacy operations. This platform will allow for an end-to-end mobile application solution whereby patients can digitize their prescription journey. The solution helps to preserve patient autonomy, improve prescription price transparency, and provide additional concierge services. Its products include Kyzatrex and Semaglutide and Tirzepatide.
Ticker SymbolWGRX
CompanyWellgistics Health Inc
CEOMr. Brian Norton
Websitehttps://wellgisticshealth.com/
Shareholders
Related Instruments
-1.69%
-0.46%
+0.12%
-0.57%
-0.75%
+0.13%
-6.42%
-0.35%
+1.72%
-0.17%
-2.98%
+1.54%
-0.29%
-0.98%
+0.13%
+0.06%
-0.84%
-0.24%
-0.69%
-0.78%Popular Instruments
52378.000
+109.000 (+0.21%)
28160.900
-37.600 (-0.13%)
7475.100
+30.800 (+0.41%)
14749.000
-90.000 (-0.61%)
62852.000
-742.000 (-1.17%)
6365.400
-1.000 (-0.02%)
85.934
+2.764 (+3.32%)
308.640
-24.790 (-7.43%)
200.760
+5.720 (+2.93%)
4041.430
-61.400 (-1.50%)